Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5164 USD | -7.62% |
|
-6.11% | -37.15% |
30/05 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
13/05 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Press Releases